Update on the pathophysiology and medical treatment of peripheral artery disease

J Golledge - Nature reviews cardiology, 2022 - nature.com
Approximately 6% of adults worldwide have atherosclerosis and thrombosis of the lower
limb arteries (peripheral artery disease (PAD)) and the prevalence is rising. PAD causes leg …

Coronary microvascular dysfunction

F Vancheri, G Longo, S Vancheri, M Henein - Journal of Clinical …, 2020 - mdpi.com
Many patients with chest pain undergoing coronary angiography do not show significant
obstructive coronary lesions. A substantial proportion of these patients have abnormalities in …

Targeting cardiovascular inflammation: next steps in clinical translation

PR Lawler, DL Bhatt, LC Godoy… - European heart …, 2021 - academic.oup.com
Systemic vascular inflammation plays multiple maladaptive roles which contribute to the
progression and destabilization of atherosclerotic cardiovascular disease (ASCVD). These …

Understanding the connection between common stroke comorbidities, their associated inflammation, and the course of the cerebral ischemia/reperfusion cascade

Ł Przykaza - Frontiers in immunology, 2021 - frontiersin.org
Despite the enormous progress in the understanding of the course of the ischemic stroke
over the last few decades, a therapy that effectively protects neurovascular units (NVUs) and …

Weight loss is a critical factor to reduce inflammation

VE Bianchi - Clinical nutrition ESPEN, 2018 - Elsevier
Background Chronic inflammation is a process sustained by the augmentation of circulating
cytokines level and C-reactive protein (CRP). Adipocytes and adipose tissue infiltration with …

The role of circulating biomarkers in peripheral arterial disease

G Saenz-Pipaon, E Martinez-Aguilar, J Orbe… - International Journal of …, 2021 - mdpi.com
Peripheral arterial disease (PAD) of the lower extremities is a chronic illness predominantly
of atherosclerotic aetiology, associated to traditional cardiovascular (CV) risk factors. It is …

Residual cardiovascular risk: When should we treat it?

F Gomez-Delgado, M Raya-Cruz, N Katsiki… - European journal of …, 2024 - Elsevier
Cardiovascular disease (CVD) still being the most common cause of death in worldwide. In
spite of development of new lipid-lowering therapies which optimize low-density lipoprotein …

Plasma biomarkers to predict cardiovascular outcome in patients with peripheral artery disease: a systematic review and meta-analysis

B Kremers, L Wübbeke, B Mees… - … , and vascular biology, 2020 - Am Heart Assoc
Objective: Patients with lower extremity peripheral artery disease (PAD) are at increased risk
of major adverse cardiovascular events. Numerous plasma biomarkers have been …

An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus

S Zaib, S Ahmad, I Khan, YA Bin Jardan… - Scientific Reports, 2024 - nature.com
The most serious long-term effects of diabetes is peripheral artery disease (PAD) which
increases the chance of developing diabetic foot ulcers, gangrene and even lower limb …

A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant …

N Martínez, M Herrera, L Frías, M Provencio… - Clinical and …, 2019 - Springer
Purpose Breast cancer patients receiving hormonal therapies face risks of relapse,
increased rates of cardiovascular events, and toxicities of therapy such as aromatase …